chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This case was reported by a physician via call center representative and described the occurrence of local reaction in a adult male patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received the 1st dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced local reaction. On an unknown date, the outcome of the local reaction was unknown. It was unknown if the reporter considered the local reaction to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported however; the patient could be 59 or 60 years old. The reporting healthcare professional was also the patient who had a localized reaction with initial dose of SHINGRIX, however no reaction with booster dose. No further details were reported. There was consent to follow up.
Child received immunizations at 1130am on 2/13/2013. Took nap, woke up crying at 1300 - crying non stop. Slept 30 minute nap, woke up crying - continues to cry. Gave TYLENOL at 1620pm, no change, still crying. Radio MD call - patient ordered MOTRIN at 1940pm per MD - (client came to clinic at 1840 to be seen for crying).
MD wrote certification regarding the need of patient to have covid-19 vaccine administered. Patient did not have any adverse effects.
This spontaneous report was received from a healthcare worker refers to an unspecified number of patients of unknown age and gender. No pertinent medical history was reported. On an unknown dates, the patients were vaccinated with 8 doses of improperly stored (Merck) VARIVAX (lot # L012038 and expiration date 07-MAR-2017) (dose and route were not reported). No adverse effects were reported. No Product Quality complaint (PQC) was involved. Additional information has been requested.
The pt was given yellow fever vaccine on 9/25/01 and was presented to health care with 25 cm local reaction at the injection site.
After getting vaccine, pt states "I can't hardly hear, I can't hardly see" to the primary nurse. Provider was sent for, and pt was placed in supine position; pt then reported anytime she saw blood or needles, she felt lightheaded. VS 1524: 91/58; 60; 16; 96% on room air. Pt awake, alert, oriented to person/place/time/situation the entire visit. During VS check, pt reports she is feeling better, back to "normal." Pt placed in upright position and given an apple juice to drink. Pt also reports she hasn't had a thing to eat/drink today. Repeat VS 1535 94/67; 74; 16; 95% on room air. Pt then ambulated to waiting area where she was observed for an additional 5 minute by provider.
Received 2nd dose of Pfizer Covid19 vaccine on 2/18/21 Had an ophthalmic procedure done to break up scar tissue around stents on 02/18/21. On 02/19/21 reported to ED after fall and hitting head  after having vertigo when getting up from toilet.
Mild headache around 10:00 am the day after vaccination (17th). Headache continued to worsen until 6:00pm when it became unbearable and moved to my eyes. Around 3:00pm lower back pain and leg pain began. It was hard to move my legs due to feeling heavy, weak, and sore.  Symptoms all seemed to worsen around 6:00pm. Called tricare  nurse line for recommendations around this time. On both feet my third and fourth toe became numb shortly after this.  I was extremely fatigued but could not sleep due to nausea. I self treated at home with an epsom salt bath and arnica. Nurse could not recommend a pain medication. I was able to sleep until 4:00am the next morning (18th). Headache persisted until the morning of the 18th. Currently, the headache and body pains have subsided. I am still tired today on the 18th.
Severe pain in foot 1 day after injection.  Pain increased about 4 hours after running.  Doctor reported bursitis in the left foot heel.
Swollen lymph nodes under left arm; Moderate pain; Some dizzy spells; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6208) via an unspecified route in the left arm on 22Mar2021 at 12:00 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. Medical history included glaucoma and high blood pressure. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive any medicines within two weeks of COVID-19 vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 23Mar2021, the patient experienced swollen lymph nodes under left arm, moderate pain and some dizzy spells. Therapeutic measures were taken as a result of pain and included treatment with OTC medication. The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. The clinical outcome of the event swollen lymph nodes under left arm, pain and dizziness was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Information has been received from a 19 year old female for the Pregnancy Registry for GARDASIL with a history of miscarriage who on 31-JUL-2007 was vaccinated intramuscularly with her first dose of GARDASIL (lot# not reported). On 03-MAR-2008 the patient was vaccinated intramuscularly with her third dose of GARDASIL (lot# not reported). Concomitant therapy included hepatitis A virus vaccine (unspecified). On 07-MAR-2008 the patient found out she was pregnant. Her LMP was 06-FEB-2008. The patient also stated that she was experiencing pain from her stomach to her knees. The pain goes away when she stays in bed, but comes back when she walks around. She did not think the pain was caused from the pregnancy. The patient's outcome was not reported. No further information is available.
Patient reports increased resting heart rate from 60-70bpm consistently prior to vaccination to 100-120bpm consistently since vaccination.  Patient also reports feeling "heart palpitations."
Warm, swollen, painful left deltoid. Clindamycin for 10 days given reported given by MA. States was diagnosed with cellulitis.
Acute onset of coughing, hard time breathing, called PCP, went to hospital EW nebulizer 4 times felt better right away.
25AUG95 mom noted red raised rash on back,trunk,face,arms,ears;sl itchy @ site of vax;,site red & size of a quarter;t103;pt seen by MD who felt it was a viral rash,unrelated to measles vax;
Client received flu shot on 10/8/15. The following day 10/9/15, client reported having loose stools x 3 which resolved on it's own. On 10/10/15, client developed itchy, scattered rashes on her chest and bilateral upper extremities and a slight fever of 99.0F. She took 25 mg BENADRYL PO at home on 10/10/15 for the rashes which resolved by 10/12/15.
hands were shaking; This spontaneous report was received from a nurse practitioner referred to an 18-year-old male patient. The patient's medical history, concurrent conditions, concomitant therapies were not reported. Concomitant therapy included unspecified COVID-19 shot.  On an unknown date, the patient was vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) injection, as prophylaxis (dose, strength, lot #, expiry date, and route of administration were not provided).   On an unknown date, after getting this shot the patient's hands were shaking (tremor). The patient had a COVID19 shot on an unknown date. The patient's mother did not clarify when the shaking began and/or if the COVID 19 shot was administered on the same visit. It was unknown whether treatment was given to the patient for event. At the time of reporting, the outcome of the event tremor was unknown. The action taken with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) regarding tremor was not applicable.   The causal relationship between tremor and hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) was unknown.
L eye sharp pain: happened twice and after that my eye feels " not normal".   Dull throbbing pain in L lower abdomen quadrant ( under ribcage )
This is a spontaneous report from a contactable consumer, the patient. A 61-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 15Apr2021 at 02:00 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient had no known allergies to medications, food or other products. The patient did not take any concomitant medication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 23Mar2021 at 01:00 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 16Apr2021 at 00:00, the patient experienced swelling nose and face. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. It was unknown if patient received any treatment for the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events swelling nose and face was not recovered at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
This spontaneous report as received from a medical assistant refers to unspecified number of patients. No medical history, concurrent conditions, concomitant medications and drug allergies were reported. On unknown dates, between 03-MAR-2015 and 20-MAR-2015, the unspecified patients were vaccinated with improperly stored VARIVAX (Merck), lot# K007784, expiration date 28-MAY-2016 or lot# K002925, expiration date 26-FEB-2016, (dose, administration route and site were not reported). No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Vaccine administered after more than 1 temperature excursion; Vaccine administered after more than 1 temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) in a 52-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031L20A and 031A21A) for COVID-19 vaccination. No Medical History information was reported. On 13-Feb-2021 at 4:04 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 20-Mar-2021 at 5:30 PM, received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .5 milliliter. On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. The age of patient was provided as 52.74 years old and 52.84 years old for two separate doses. Concomitant products were not provided. On 13-Feb-2021, Excursion time was 09. Temperature was 32. Total doses given for the day was 152, condition of vaccine prior to administration was not frozen, vaccine was moved to fridge on 09-Feb-2021, vial was moved to clinic on 13-Jan-2021. 30 vials were sent to clinic. Vaccine BUD date was 10-Mar-2021. On 20-Mar-2021, Excursion time was 09 AM and 10 AM. Temperature was 34 and 37. Total doses given for the day was 184, condition of vaccine prior to administration was not frozen, vaccine was moved to fridge on 09-Mar-2021, vial was moved to clinic on 20-Mar-2021. 19 vials were sent to clinic. Vaccine BUD date was 08-Apr-2021. On 20-Mar-2021, vials were stored in cooler 1, at following time and temperature respectively, 8 AM: Unknown, 9 AM: 34, 10 AM: 30, 11 AM: 41, 12 AM: 45, 1PM: 44, 2 PM: 44, 3 PM: 44, 4 PM: 44 and 5 PM: 43. The vials were only punctured right before administration and all doses were drawn from the vial due to high-pace clinic. Temperature recordings were taken using a traceable temperature monitor at every hour. After administration, the vial was returned to the freezer/refrigerator, or maintained at room temperature. It was reported that the patient was administered with vaccines that experienced more than 1 temperature excursion during 33 weeks in 2021. The HCP explained that each time a vial was put into a cooler, there was a period of 1 hour or 1 and half hour approximately, when the temperature data logger registered 34 or 35 degree F. Treatment medications were not reported.
My uncle, died on February 17, 2021.  He was admitted on February 2, 2021 6 days after taking the COVID-19 Moderna vaccine (1/28/2021).  After the shot was administered, he developed all the COVID-19 symptoms (loss of taste, smell, high temperature, and had trouble breathing).  He was deprived of oxygen and had labored breathing and was acting confused.  The home health nurse contacted his primary care physician and was instructed to bring him into  the ER.
Terrible arm pain; This is a spontaneous report from a contactable other HCP (Patient's parent).  A 29-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 1 intramuscular, administered in Arm Right on 24Sep2021 13:00 (Batch/Lot number was not reported) age at vaccination of 29-years-old, as single dose, for covid-19 immunisation.  Medical history included drug hypersensitivity from an unknown date and unknown if ongoing (Penicillin allergy), covid-19 from an unknown date and unknown if ongoing if covid prior vaccination. The patient was not pregnant and was not pregnant at the time of vaccination. There were no concomitant medications. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced terrible arm (non-serious) on 24Sep2021 13:30. Facility where the most recent COVID-19 vaccine was administered: Pharmacy or Drug Store. Since the vaccination, the patient has not been tested for COVID-19. Outcome of the event was not recovered.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
(Lt) upper thigh with edema, induration & warmth day following routine imm. Afebrile. Seen in office x 2 days after imm. given. TX PRN with TYLENOL or MOTRIN; gave BENADRYL.
Nasal congestion gradually increasing for a day or so and continuing 4 days later.  Cough started the next day and continues.  Slight fever.  Went to family doctor on 1/18/2010.  Was diagnosed bronchitis and given antibiotic prescription (azithromycin), plus ProAir HFA inhaler and Mucinex.
Pt received janssen Covid 19 vaccine 518pm. Pt went to the waiting area chairs and within 2 minutes she was losing consciousness. Myself and another customer were able to lower patient to the floor (did not hit head). She lost all muscle tone, consciousness and bladder control (urinating on herself/floor). Sternal rub was able to get the patient to regain consciousness. Took blood pressure at 522pm and was 152/95 with pulse of 95. Arm was hot to touch and patient was sweaty. Placed a cold pack on injection site and fanned pt until EMS arrived for evaluation. EMS loaded pt on a stretcher and took to ambulance to evaluate heart rhythm.
diarrhea; passing gas; Burping; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea), FLATULENCE (passing gas) and ERUCTATION (Burping) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M204) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 06-Feb-2021, the patient experienced DIARRHOEA (diarrhea), FLATULENCE (passing gas) and ERUCTATION (Burping). At the time of the report, DIARRHOEA (diarrhea) and ERUCTATION (Burping) had resolved and FLATULENCE (passing gas) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient had diarrhea, stomach was making noises, he is passing gas and has a bit of burping. It all continues through today. He wants to know if this is normal. He wants to know if he should receive the 2nd vaccine. As Per reporter, first episode of diarrhea occurred for 3 weeks after receiving his initial vaccine. He further reports that second episode of diarrhea occurred for 4 days following receipt of the second dose of the vaccine. He states that all symptoms have resolved and that he did not seek medical attention
I got a rash like symptom, it looked like mosquito bites ALL OVER  my legs and arms. It itches A LOt and ends up red when I scratch. It ended up actually worsening so I went to urgent care and was told that my immune system was just reacting to vaccine. I was prescribed a stronger benadryl .
Rash developed one month after the vaccine was given. Rash is red, bumps, painful on arms and legs. Was seen by PCP and given PREDNISONE. Continues to have painful rash as of 6/4/09.
I started feeling an irritation in my throat, not quite a cough but felt like it could be a cough, so I started eating cough drops. It was bothering me a lot because of my C-Pap, and I was getting a lot of drainage and sliminess down my throat. It caused me to lose my voice, I could barely talk for five days. I had mostly bad fatigue, and a low grade fever, I never got a high fever because every time I took the temp it was just a low grade fever. I was eating copious amounts of cough drops to battle the tickle feeling. My PCP wouldn't see me so I went to the pharmacy clinic, but because they couldn't access my records she was unable to prescribe PAXLOVID, and instead gave me LAGEVRIO, which is less effective but no rebound. I was taking over the counter flu medication and the Pharmacist suggested to switch to the DM and acetaminophen, cough suppressant, and a nasal saline solution. Eventually the drippy stuff in the back of my throat slowed down and by a week later my voice was back. It was probably about 3 weeks after before I started to regain my energy levels.
Pt recvd 3 doses of Engerix-B & did not convert; pt recvd 4th dose of booster & still had a neg titer;
ITCHINESS; DIFFICULTY BREATHING; PAIN IN ARM AND LEG; HEADACHE; This spontaneous report received from a consumer concerned a 6 decade old female. The patient's height, and weight were not reported. The patient's concurrent conditions included: drug allergy, diabetes, and swelling, and other pre-existing medical conditions included: Patient had problem with salt and swelling for which she uses diuretic. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on APR-2021 for prophylactic vaccination. The batch number was not reported. The company is unable to perform follow-up to request batch and lot numbers. Concomitant medications included insulin for diabetes.  On AUG-2021, the patient experienced itchiness. On AUG-2021, the patient experienced difficulty breathing. On AUG-2021, the patient experienced pain in arm and leg. On AUG-2021, the patient experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the pain in arm and leg, headache, itchiness and difficulty breathing was not reported. This report was non-serious.
Information has been received from a physician concerning a 5 year old male (40 in, 32 lb) with an allergy to beef gelatin and on other pertinent medical history who on 15-OCT-2007 was vaccinated with VARIVAX (Merck) and the flu vaccine.  Within one minute of these injections, the patient had an acute allergic reaction (erythema, sneezy, coughing and listless). Subsequently the patient went to the emergency room where he was treated with epidural, BENADRYL and unspecified steroids.  On an unspecified date, the patient recovered from the event.  Additional information is not expected.
Information has been received regarding a case in litigation concerning an approximately 18 month old male who on was injection IM with vaccinations containing the mercury base preservative thimerosal. The alleged results of the vaccinations is the patient suffered mercury toxicity and permanent neurological injuries, and associated complications and sequelae with aggravation of other conditions directly through exposure via IM injections of mercury. In approximately 4/00, at approximately 18 months of age, the patient suddenly regressed developmentally, losing milestones of neurological development previously achieved specifically including but not limited to becoming withdrawn, unable to speak, unresponsive to his environment, engaging in repetitive behavior and loss of language skills, motor skills and affect. Immunization information indicated that the patient was injected with the following vaccines that contained thimerosal: Haemophilus B conjugate vaccine on 12/21/98, 2/22/99 and 2/10/00. Concomitant therapy included diphtheria toxoid/pertussis vaccine/teta on 12/27/98, 2/22/99, 4/24/99 and 2/10/00; and hepatitis B vaccine recombinant on 11/19/98 and 2/10/00. Upon internal review, the patient's mercury poisoning and neurological disorder were considered other important medical events. No further information is available.
I received the vaccine at 10:00a on 12/16. Early the next morning at around 05:00-06:00 I experienced slight fever (99.3F), body aches, headaches, and felt feverish. The symptoms subsided after I slept for the rest of the morning but I felt somewhat fatigued for the rest of the day. The next day I felt fine with no symptoms.
18 Days after small pox and anthrax vaccination he noted onset of mildly symptomatic and diffuse papular rash, No systemic or ill symptoms. Impression nonspecific papular rash most likely hive to small pox. Supportive therapy given
Administered DTaP, IPOL, MMR witout incident immediately following, bumped head on wall, blacked out, unconscious for brief seconds. Regained consciousness. BP 82/64, O2 99%, P 110. Referred to ER to follow up. Agreed without arguments. Support and reassurance given.
Client's mother reported to staff that client's arm hurt immediately after injection. Both client and mother attested this to having just received an IM injection. Client reported that her arm continued to hurt. Client reported about 2 hours after the injection, while at home, client's arm pain continued to increase and client was reporting sharp, burning pain to her arm and shoulder and limited range of motion to the point client was unable to use her right arm for activities of daily living (ADL's). Mother gave client ibuprofen and had client ice her arm/shoulder.